Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Kenney Richard T | Chief Medical Officer | 100 OVERLOOK CENTER, SUITE 102, PRINCETON, | /s/ Richard T. Kenney | 2025-07-15 | 0001606653 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SONN | Common Stock | Award | +8K | +582.24% | 9.37K | Jul 11, 2025 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | On July 11, 2025, the Reporting Person was granted 8,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan). |
F2 | Includes unvested restricted stock units. |
F3 | All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024. |